Related content

Peptide receptor radionuclide therapy with 90 Y-DOTATOC in recurrent meningioma

By Bartolomei Mirco  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 36, Iss. 9, 2009-09 ,pp. : 1407-1416

Springer Publishing Company

Access to resources Recommend Favorite

Receptor radionuclide therapy with ⁹⁰Y-[DOTA]⁰-Tyr³-octreotide (⁹⁰Y-DOTATOC) in neuroendocrine tumours

By Bodei Lisa   Cremonesi Marta   Grana Chiara   Rocca Paola   Bartolomei Mirco   Chinol Marco   Paganelli Giovanni  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 7, 2004-07 ,pp. : 1038-1046

Springer Publishing Company

Access to resources Recommend Favorite

Developing the radiation protection safety culture in the UK

By Cole P   Hallard R   Broughton J   Coates R   Croft J   Davies K   Devine I   Lewis C   Marsden P   Marsh A   McGeary R   Riley P   Rogers A   Rycraft H   Shaw A  

Journal of Radiological Protection, Vol. 34, Iss. 2, 2014-06 ,pp. : 469-484

IOP Publishing

Access to resources Recommend Favorite

Radiation exposure during liver surgery after treatment with 90 Y microspheres, evaluated with computer simulations and dosimeter measurements

By Högberg Jonas   Rizell Magnus   Hultborn Ragnar   Svensson Johanna   Henrikson Olof   Gjertsson Peter   Bernhardt Peter  

Journal of Radiological Protection, Vol. 32, Iss. 4, 2012-12 ,pp. : 439-446

IOP Publishing

Access to resources Recommend Favorite

Extra-hepatic embolisation of Y-90 microspheres from selective internal radiation therapy (SIRT) of the liver

By Thamboo Thomas   Tan Kong-Bing   Wang Shih-Chang   Salto-Tellez Manuel  

Pathology, Vol. 35, Iss. 4, 2003-08 ,pp. : 351-353

Ashgate Publishing Ltd

Access to resources Recommend Favorite